Who Owns Intuitive Surgical Company?

Intuitive Surgical Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who owns Intuitive Surgical now?

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, rose to prominence after its 2000 Nasdaq IPO. Its da Vinci platform led to >8,600 systems installed by Q2 2025 and supported over 2.3 million procedures in 2024. Ownership shifted from founders to large institutions and index funds.

Who Owns Intuitive Surgical Company?

Major holders are institutional investors and ETFs, with insiders holding modest stakes and board members influencing strategy; see a product analysis here: Intuitive Surgical Porter's Five Forces Analysis

Who Founded Intuitive Surgical?

Founders and early ownership of Intuitive Surgical trace to 1995 when Frederic H. Moll, M.D., John Gordon Freund, M.D., and Robert G. Younge founded the company with early engineering leadership from James (Jamie) Simpson and IP collaboration from SRI International; initial equity was held by founders, early employees and seed investors though exact percentage splits were not publicly disclosed.

Icon

Founding team

The company was founded in 1995 by Dr. Frederic H. Moll, Dr. John G. Freund and Robert G. Younge, with key engineering input from James Simpson.

Icon

SRI International role

Technologists from SRI contributed pivotal telemanipulation and endoscopic robotics IP and supported early technology transfer and seed funding relationships.

Icon

Seed and angel funding

Early angels and SRI-related transfers provided seed capital; precise initial ownership percentages were not publicly disclosed.

Icon

Venture backers

Late-1990s venture rounds included institutional backers such as Mayfield Fund, creating preferred stock seniority and investor board seats.

Icon

Founder vesting

Founders were typically subject to four-year vesting with one-year cliffs and protective buy-sell clauses consistent with Silicon Valley term sheets of that era.

Icon

Equity dilution pre-IPO

Successive venture financings before the 2000s IPO diluted founder stakes; governance shifted to investor-led boards focused on FDA clearance and commercial scale-up.

Dr. Moll later stepped back from operational roles in the early 2000s and pursued other robotics ventures; there were no widely reported founder equity litigation events, and early governance choices prioritized regulatory milestones such as FDA clearance of the da Vinci system in 2000.

Icon

Key early-ownership facts

Founders, early employees and institutional investors shaped the initial shareholder structure; later public filings show major shareholders and institutional concentration evolved post-IPO.

  • Founders: Frederic H. Moll, John G. Freund, Robert G. Younge and engineering leads like James Simpson.
  • Early IP and seed support: contributions from SRI International and angel investors.
  • Venture rounds: Mayfield Fund among early institutional backers creating preferred stock priorities pre-IPO.
  • Regulatory milestone: FDA clearance in 2000 materially drove governance and commercial strategy.

For broader context on ownership evolution, see the detailed company analysis in Marketing Strategy of Intuitive Surgical.

Intuitive Surgical SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has Intuitive Surgical’s Ownership Changed Over Time?

Key events reshaping Intuitive Surgical ownership include the 2000 Nasdaq IPO that moved shares from founders and VCs to public hands, the 2003–2010 commercial scale-up and index inclusion that broadened institutional and passive holders, the 2012–2018 maturation with rising institutional ownership through dilution, and the 2019–2025 leadership era under CEO Gary S. Guthart that reinforced passive-dominant, long-term ownership.

Period Inflection Point Ownership Impact
2000 IPO Nasdaq listing (ISRG), priced at $9 per share; ~ $46M raised Transition from concentrated VC/founder stakes to diversified public float; valuation moved to several hundred million
2003–2010 Rapid system placements, recurring revenue, international expansion Market cap rose to multi‑billion; index inclusion pulled large mutual funds and passive investors into register
2012–2018 Ecosystem buildout: training, services, procedure growth Institutional ownership grew; insiders’ relative stakes declined mainly via dilution, not large secondary sell‑downs
2019–2025 New platforms (Ion), broader indications; leadership continuity Passive index ownership solidified, supporting stability and lower cost of capital

Current ownership (2024–2025) features dominant institutional holders, modest insider stakes, and an effectively fully free‑floating register.

Icon

Ownership snapshot and implications

Major shareholders are mainly large asset managers and sovereign/pension funds, with insiders holding low single digits; share count and passive ownership shape governance and strategy.

  • As of FY2024, shares outstanding ~ 355–360 million
  • Vanguard and BlackRock together often represent roughly 15–20%+ of outstanding stock
  • Other significant institutions: State Street, Fidelity (FMR), Capital Group, Norges Bank, large pension funds
  • Insider ownership: generally low single digits across executives and directors; no controlling founder

Key implications for investors: who owns Intuitive Surgical matters for governance, cost of capital, and strategic focus on ecosystem lock‑in and clinical evidence; for a deeper market profile see Target Market of Intuitive Surgical.

Intuitive Surgical PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on Intuitive Surgical’s Board?

As of 2025 the board of directors of Intuitive Surgical includes CEO Gary S. Guthart, Ph.D., and independent directors such as Craig H. Barratt, Ph.D., Amal M. Johnson, Alan J. Levy, Ph.D., Mark J. Rubash, Amy L. Ladd, M.D., Frances Frei, Ph.D., and Julian M. Castaneda; composition may vary after the 2025 annual meeting.

Director Role / Background Independence
Gary S. Guthart, Ph.D. Chief Executive Officer; long-tenured executive Executive
Craig H. Barratt, Ph.D. Technology and operations executive; board member Independent
Amal M. Johnson Corporate governance and finance experience Independent
Alan J. Levy, Ph.D. Medical device / clinical expertise Independent
Mark J. Rubash Orthopedic and clinical leadership Independent
Amy L. Ladd, M.D. Clinical and surgical expertise Independent
Frances Frei, Ph.D. Organizational leadership and strategy Independent
Julian M. Castaneda Corporate governance / advisory roles Independent

Directors oversee audit, compensation, nominating/governance, and technology/clinical advisory committees; major institutional investors do not hold designated board seats, consistent with a mature large-cap governance model.

Icon

Board and Voting Power Highlights

The company uses a one-share-one-vote structure with no dual-class or super-voting stock; institutional influence is exerted through proxy voting rather than board appointments.

  • Voting structure: one-share-one-vote; no dual-class shares
  • Proxy outcomes often follow ISS or Glass Lewis and large index managers
  • Activist activity limited given strong margins (~66–71% gross margin in 2023–2024) and cash generation
  • Board refreshment and executive compensation are routine governance engagement topics

Intuitive Surgical ownership is concentrated among large institutional investors (Vanguard, BlackRock among the largest holders by assets under management in 2024–2025), with no controlling shareholder; for deeper context see Competitors Landscape of Intuitive Surgical.

Intuitive Surgical Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped Intuitive Surgical’s Ownership Landscape?

From 2019 through 2025 Intuitive Surgical ownership trended toward greater passive institutional concentration, with Vanguard and BlackRock notably increasing combined stakes alongside rising S&P 500 and Nasdaq‑100 AUM; insider ownership remained modest while equity compensation drove modest share count drift.

Trend Evidence / Data
Passive institutional growth Vanguard and BlackRock combined among top holders; indexation growth paralleled S&P 500/Nasdaq‑100 AUM expansion through 2024–2025
Insider & executive ownership Modest direct holdings; compensation mainly RSUs/PSUs with scheduled vesting causing share count drift
Capital allocation Prioritized R&D, training sites, manufacturing capacity; opportunistic repurchases, no regular dividend as of 2025

Between 2023 and 2025 Intuitive expanded the Ion platform and advanced the next‑gen da Vinci program without large transformational M&A that would alter shareholder mix; procedure volume rose about 22% in 2023 with continued double‑digit growth in 2024, supporting a strong balance sheet (multi‑billion dollars cash, no net debt) and reducing activist pressure.

Icon Institutional ownership concentration

Large‑cap medtech ownership skews institutional and passive; analysts expect this to remain dominant for Intuitive Surgical with top mutual funds and ETFs retaining material positions.

Icon Insider compensation and dilution

Executive pay largely RSUs/PSUs; models project incremental dilution from ongoing grants rather than one‑time dilution events.

Icon Governance and activism risk

Strong procedure growth and cash position temper activism risk; no founder control or dual‑class structure exists, and management has signaled board refreshment and succession planning.

Icon Where to find filings

Beneficial ownership and insider trades appear in SEC filings and proxy statements; readers can reference institutional holdings lists and 13D/13G filings for percentage ownership by Vanguard and BlackRock.

For context on business drivers that influence ownership dynamics see Revenue Streams & Business Model of Intuitive Surgical

Intuitive Surgical Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.